A high level of transmembrane serine protease 4 (TMPRSS4) is associated with the poor prognosis of patients with non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, and other cancers. This evidence concerns the gene TMPRSS4 and prostate carcinoma.